Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

EGLT / Egalet Corporation EX-3.1

2018-02-17 sec.gov
Exhibit 3.1   CERTIFICATE OF AMENDMENT OF THE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EGALET CORPORATION   EGALET CORPORATION, a corporation incorporated under its current name on August 21, 2013 and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”) does hereby certify:   FIRST: That, at a meeting of the Board of Directors on December 8, 2017, a resolution was duly adopted setting forth a proposed amendment to the Third Am

EGLT / Egalet Corporation 8-K (Current Report)

2018-02-17 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): February 14, 2018     Egalet Corporation (Exact name of Registrant as specified in its charter)     Delaware   001-36295   46-3575334 (State or Other Jurisdiction of Incorporation or Organization)   (Commission File Number)   (I.

EGLT / Egalet Corporation / Alyeska Investment Group, L.P. - 3G (Passive Investment)

2018-02-16 sec.gov
_____________________ | OMB APPROVAL | |_____________________| |OMB NUMBER: | UNITED STATES |EXPIRES: | SECURITIES AND EXCHANGE COMMISSION | JUNE 30, 2012 | Washington, D.C. 20549 |ESTIMATED AVERAGE | |BURDEN HOURS | |PER RESPONSE ...11 | SCHEDULE 13G _____________________| Under the Securities Exchange Act of 1934 (Amendment No. _ )* Egalet Corporation (EGLT) --------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------- (Title of C

EGLT / Egalet Corporation / Index Venture Associates III Ltd - SC 13G (Passive Investment)

2018-02-16 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. ___)*   Egalet Corporation (Name of Issuer)   Common Stock, par value $0.001 per share (Title of Class of Securities)   28226B104 (CUSIP Number)   December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule

EGLT / Egalet Corporation / Index Venture Associates III Ltd - SC 13G (Passive Investment)

2018-02-16 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. ___)*   Egalet Corporation (Name of Issuer)   Common Stock, par value $0.001 per share (Title of Class of Securities)   28226B104 (CUSIP Number)   December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule

EGLT / Egalet Corporation / Alyeska Investment Group, L.P. - 3G (Passive Investment)

2018-02-16 sec.gov
_____________________ | OMB APPROVAL | |_____________________| |OMB NUMBER: | UNITED STATES |EXPIRES: | SECURITIES AND EXCHANGE COMMISSION | JUNE 30, 2012 | Washington, D.C. 20549 |ESTIMATED AVERAGE | |BURDEN HOURS | |PER RESPONSE ...11 | SCHEDULE 13G _____________________| Under the Securities Exchange Act of 1934 (Amendment No. _ )* Egalet Corporation (EGLT) --------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------- (Title of C

EGLT / Egalet Corporation / HIGHBRIDGE CAPITAL MANAGEMENT LLC - EGALET CORPORATION (Passive Investment)

2018-02-14 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       SCHEDULE 13G/A       Under the Securities Exchange Act of 1934   (Amendment No. 1)*   Egalet Corporation (Name of Issuer)   Common Stock, par value $0.001 per share (Title of Class of Securities)   28226B104 (CUSIP Number)   December 31, 2017 (Date of event which requires filing of this statement)   Check the appropriate box to designate the rule pursuant to which this Schedule 13G/A is filed:   ☐    Rule 13d-1(b) ☒    Rule 13d-1(

EGLT / Egalet Corporation / HIGHBRIDGE CAPITAL MANAGEMENT LLC - EGALET CORPORATION (Passive Investment)

2018-02-14 sec.gov
  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       SCHEDULE 13G/A       Under the Securities Exchange Act of 1934   (Amendment No. 1)*   Egalet Corporation (Name of Issuer)   Common Stock, par value $0.001 per share (Title of Class of Securities)   28226B104 (CUSIP Number)   December 31, 2017 (Date of event which requires filing of this statement)   Check the appropriate box to designate the rule pursuant to which this Schedule 13G/A is filed:   ☐    Rule 13d-1(b) ☒    Rule 13d-1(

EGLT / Egalet Corporation - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-12 fintel.io
Egalet Corporation (NASDAQ:EGLT) has 67 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,285,493 shares. Largest shareholders include Broadfin Capital, LLC, Highbridge Capital Management Llc, Omega Fund Management, LLC, Franklin Resources Inc, Armistice Capital, Llc, Alyeska Investment Group, L. (108-0)

EGLT / Egalet Corporation / Atlas Venture Fund VII L P - SC 13G/A (Passive Investment)

2018-02-12 sec.gov
    UNITED STATES     SECURITIES AND EXCHANGE COMMISSION     Washington, D.C. 20549         SCHEDULE 13G (Rule 13d-102)   Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934   (Amendment No. 3)*   EGALET CORPORATION   Common stock,  $0.001 (Title of Class of Securities) 28226B104 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f

EGLT / Egalet Corporation / Atlas Venture Fund VII L P - SC 13G/A (Passive Investment)

2018-02-12 sec.gov
    UNITED STATES     SECURITIES AND EXCHANGE COMMISSION     Washington, D.C. 20549         SCHEDULE 13G (Rule 13d-102)   Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934   (Amendment No. 3)*   EGALET CORPORATION   Common stock,  $0.001 (Title of Class of Securities) 28226B104 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f

EGLT / Egalet Corporation DEF 14A

2018-01-08 sec.gov
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.          ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o   Preliminary Proxy Statement o   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý   Definit

Your Daily Pharma Scoop: Ardelyx Reports Data, Omeros Moves Forward With OMS721, Allergan Announces Job Cuts

2018-01-04 seekingalpha
Omeros reached an agreement with FDA on design of Phase 3 trial for OMS 721 in IgN. (654-2)

EGLT / Egalet Corporation - EGLT / Egalet Corporation / Broadfin Capital, LLC - 3G (Passive Investment) - Fintel.io

2018-01-04 fintel.io
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. (36-3)

Cyrus Capital Partners, L.p. - All Holdings - 13F 13D 13G Filings - Fintel.io

2018-01-03 fintel.io
Cyrus Capital Partners, L.p. has disclosed 14 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 771,716,000 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Cyrus Capital Partners, L.p.'s top holdings are Ally Financial Inc. (NYSE:ALLY) , Delta Air Lines, Inc. (NYSE:DAL) , United Continental Holdings, Inc. (NYSE:UAL) , International Seaways, Inc. (85-3)


EGLT : Egalet Corporation Stock Analysis and Research Report

Egalet Corporation is a fully integrated specialty pharmaceutical company developing, manufacturing and commercializing innovative treatments for pain and other conditions. Given the need for acute and chronic pain products and the issue of prescription abuse, the company focused on bringing non-narcotic and abuse-deterrent (“AD”) opioid formulations to patients and physicians. Egalet is currently marketing ARYMO® ER (morphine sulfate) extended-release (“ER”) tablets, for oral use CII (“ARYMO ER”), SPRIX® (ketorolac tromethamine) Nasal Spray (“SPRIX Nasal Spray”), and OXAYDO® (oxycodone HCI, USP) tablets for oral use only—CII (“OXAYDO”).

ARYMO ER, an ER morphine product formulated with abuse-deterrent properties and approved for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate, is its first product developed using its proprietary Guardian™ Technology. Egalet acquired, and...

Click for full article
CUSIP: 28226B104